TNBC is defined by its lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression; and accounts for 10–20% of all breast cancers [2, 3]. This evidence concerns the gene ESR1 and breast carcinoma.